Program
There are limited number of programs which are available in English.
Please check it for the sessions available in English.
Invited Lecture
Invited Lecture１
Saturday, July 6, 2024 8:40-9:20 Room1
From the Heart to the Population
Chair Hitoshi Shimano（University of Tsukuba）
Speaker Kaushik Ray（Imperial College London）
Invited Lecture２
Saturday, July 6, 2024 9:30-10:10 Room1
New Lipid Therapies for Targeting Cardiometabolic Risk
Chair Ken-ichi Hirata（Kobe University Graduate School of Medicine）
Speaker Stephen Nicholls（Monash University）
Invited Lecture３
Saturday, July 6, 2024 10:20-11:00 Room1
How genetic variants in children with Familial Hypercholesterolemia not only guide detection, but also treatment
Chair Shizuya Yamashita (Department of Cardiology, Rinku General Medical Center)
Speaker Albert Wiegman（Amsterdam University Medical Centre）
Special Lecture
Saturday, July 6, 2024 11:10-11:40 Room1
Atherosclerotic Cardiovascular Disease (ASCVD) Prediction: The United States Pooling Project(ARIC, FRAMINGHAM, & MESA)
Chair Koutaro Yokote（Chiba University Hospital）
Speaker Ernst Schaefer（Tufts University School of Medicine）
The 9th Shimamoto Takio Memorial Lecture
Sunday, July 7, 2024 9:00-10:30 Room1
「Revolutionizing Cardiovascular Health: The Future of Single-Course In Vivo Genome Editing」
Chair Atsushi Nohara（Ishikawa Prefectural Central Hospital）
Ken-ichi Hirata（Kobe University Graduate School of Medicine）
From reading the genome for risk to rewriting it for cardiovascular health
Speaker Sekar Kathiresan（Verve Therapeutics, Inc.）
Potent, Specific, and Durable Liver Editing of PCSK9 in Preclinical Studies of the CRISPR Base Editing Medicine VERVE-101
Taiji Mizoguchi（Verve Therapeutics, Inc.）
Symposium３
「Experiences from Clinical Trials in Japan and Foreign Countries」
Saturday, July 6, 2024 10:20-11:50 Room２
Chair Yu Kataoka (National Cerebral & Cardiovascular Center)
Stephen Nicholls（Monash University）
Speaker Teruo Noguchi（National Cerebral & Cardiovascular Medicine）
Kenichi Tsujita（Graduate School of Medical Sciences, Kumamoto University）
Satoshi Yasuda （Tohoku University Graduate School of Medicine）
Kaushik Ray（Imperial College London）
Stephen J. Nicholls（Monash University）
KSoLA-JAS Joint Symposium
「Comparison of Epidemiological Studies on Arteriosclerosis between Japan and Korea」
Sunday, July 7, 2024 10:20-11:50 Room５
Chair Tomonori Okamura（Department of Preventive Medicine and Public Health, School of Medicine Keio University,Japan）
Eun-Jung Rhee（ Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea）
Speaker Toshiharu Ninomiya（Department of Epidemiology and Public Health,Graduate School of Medical Sciences, Kyushu University, Japan）
Hirohito Sone(Department of Internal Medicine, Niigata University Faculty of Medicine, and Big Data Activation Research Center of Niigata University, Japan)
Eun-Jung Rhee（ Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea）
Hokyou Lee（Yonsei University）
APSAVD-IAS-JAS Joint Symposium
(Sponsored by Kowa Company, Ltd.)
「Cardiovascular Risk Management in Patients with Diabetes」
Sunday, July 7, 2024 14:10-15:50 Room４
Chair Richard O’Brien (Immediate Past President of APSAVD / University of Melbourne, Australia)
Shizuya Yamashita (Rinku General Medical Center, Japan)
Speaker Nuntakorn Thongtang (Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand)
Wang Weiqing (Endocrinology Department of Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China)
Yusaku Mori (Showa University School of Medicine, Japan)
Brendan M. Everett (Brigham and Women’s Hospital, U. S.)
Luncheon Seminar
Luncheon Seminar1（Sponsored by Ultragenyx Japa）
「Real-world experience with anti-ANGPTL3 antibody (Evinacumab) therapy in patients with Homozygous familial hypercholesterolemia」
Saturday, July 6, 2024 12:00-12:50 Room２
Chair Mariko Harada-Shiba (Osaka Medical and Pharmaceutical University)
Speaker Albert Wiegman（Amsterdam University Medical Centre)
Luncheon Seminar2（Sponsored by NewAmsterdam Pharma）
「Innovating the clinical management of LDL-c: Exploring CETP as therapeutic target」
Saturday, July 6, 2024 12:00-12:50 Room３
Chair John Kastelein（Amsterdam University Medical Centre）
Speaker John Kastelein（Amsterdam University Medical Centre）
Stephen Nicholls（Monash University）